P. Jalava

Quantitation of erbB2 positivity for evaluation of high-risk patients

P. Kronqvist, T. Kuopio, Y. Collan, 2002, Annals of medicine.

Bcl-2 immunostaining: a way to finding unresponsive postmenopausal N+ breast cancer patients.

P. Kronqvist, T. Kuopio, Y. Collan, 2000, Anticancer research.

Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer

P. Kronqvist, T. Kuopio, Y. Collan, 2002, British Journal of Cancer.

Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.

T. Kuopio, Y. Collan, R. Huovinen, 2005, Anticancer research.

Cysteine proteinase inhibitor cystatin A in breast cancer.

P Kronqvist, P. Kronqvist, T. Kuopio, 1998, Cancer research.

Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index

P Kronqvist, P. Kronqvist, T. Kuopio, 2006, Histopathology.

Breast cancer prediction using a neural network model

B. Back, l. Nastac, P. Jalava, 2004, Proceedings World Automation Congress, 2004..

Nuclear volume and breast cancer prognosis.

P. Kronqvist, T. Kuopio, Y. Collan, 2001, Anticancer research.